Press Releases

Aug 6, 2026

Jordan Park

Press Releases

Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure

Mangoceuticals announced that Nuclea Energy, its merger partner, has signed a non-binding MOU with New Mining Co. to assess the feasibility of deploying Nuclea's advanced modular nuclear reactors to provide behind-the-meter power for New Mining's high-density Bitcoin mining data centers. The phased evaluation could lead to up to 100 MWe capacity, s…

MGRX

Aug 6, 2026

Hana Yamamoto

Press Releases

Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update

Opus Genetics, a clinical-stage biopharmaceutical company focused on gene therapies for inherited retinal diseases, announced second quarter 2026 financial results and provided updates on its pipeline. Key milestones include completion of enrollment in the OPGx-LCA5 registrational trial with dosing planned for Q4 2026, upcoming topline data from OP…

IRD

Aug 6, 2026

Nina Shah

Press Releases

Cullinan Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Cullinan Therapeutics provided an update on its clinical programs advancing T cell engagers for autoimmune diseases and cancer, highlighting upcoming multi-dose regimen data for CLN-978 and velinotamig, progression to Phase 2 studies in 2027, and a potentially registrational Phase 2 trial for CLN-049 in relapsed/refractory AML starting Q3 2026. The…

CGEM

Aug 6, 2026

Maya Rios

Press Releases

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates

Avalo Therapeutics reported second quarter 2026 financial results highlighting positive topline Phase 2 results for its lead drug candidate, abdakibart, in hidradenitis suppurativa (HS). The company plans to initiate a registrational Phase 3 clinical program in the first half of 2027 and has expanded its pipeline with AVTX-010, a next-generation an…

AVTX

Aug 6, 2026

Nina Shah

Press Releases

Monte Rosa Therapeutics Announces Second Quarter 2026 Financial Results and Business Updates

Monte Rosa Therapeutics announced robust Q2 2026 results featuring significant clinical and development milestones, including completed enrollment in a key MRT-8102 study targeting cardiovascular disease risk, activation of multiple Phase 2 trials across inflammatory and oncology programs, and a strong financial position with $626 million in cash t…

GLUE

Aug 6, 2026

Priya Menon

Press Releases

Generate Biomedicines Inc. Reports Second Quarter 2026 Financial Results and Provides Business Update

Generate Biomedicines Inc. reported continued progress in its clinical programs and platform advancements during Q2 2026. The company is advancing its Phase 3 SOLAIRIA studies for GB-0895 in severe asthma, enrolling patients globally, and will present Phase 1b data for GB-0895 in COPD at the ERS Congress. It also dosed the first cohort in a Phase 1…

GENB

Aug 6, 2026

Caleb Monroe

Press Releases

Ligand Reports Second Quarter 2026 Financial Results

Ligand Pharmaceuticals reported robust second quarter 2026 financial results with a 32% year-over-year growth in royalty revenue, raising the low end of its adjusted EPS guidance while maintaining revenue guidance. The company completed a $700 million zero-interest convertible debt financing and finalized the acquisition of XOMA Royalty, significan…

LGND

Aug 6, 2026

Derek Hwang

Press Releases

Macerich Announces Proposed Offering of Exchangeable Senior Notes

The Macerich Company announced its operating partnership's intent to offer $600 million in exchangeable senior notes due 2031 through a private placement targeting qualified institutional buyers. The notes offer semi-annual interest and will be guaranteed by Macerich on a senior unsecured basis. Proceeds will be used to refinance existing secured d…

MAC

Aug 6, 2026

Sofia Navarro

Press Releases

GPGI Reports Second Quarter 2026 Results

GPGI, Inc. announced its Q2 2026 financial results, showing a 4% decrease in pro forma adjusted net sales to $473.2 million and a 13% decline in pro forma adjusted EBITDA to $113.9 million, with margins down 230 basis points. Notably, CompoSecure delivered record performance driven by ROS-enabled improvements, while Husky met expectations amid mark…

GPGI

Aug 6, 2026

Nina Shah

Press Releases

CareCloud Reports Second Quarter 2026 Results

CareCloud, Inc. announced its Q2 2026 financial results showing 16% revenue growth to $31.9 million and sustained profitability with a GAAP net income of $1.1 million. The company expanded its product portfolio by acquiring Empower Healthcare & Compliance Partners, entering the compliance and audit-defense market. CareCloud reaffirmed its full-year…

CCLD

Aug 6, 2026

Leila Farooq

Press Releases

Harrow Acquires Global Rights to TYRVAYA®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

Harrow, Inc. announced the acquisition of TYRVAYA®, a novel nasal spray treatment for dry eye disease, from Viatris Inc., aiming to enhance its ophthalmic product portfolio. TYRVAYA offers an alternative to eye drops with a unique delivery method and complements Harrow's existing products, expanding treatment options for dry eye sufferers. The acqu…

HROW

Aug 6, 2026

Derek Hwang

Press Releases

Gogo Announces Second Quarter Results

Gogo Inc., a leading provider of broadband connectivity solutions for business and military aviation markets, announced Q2 2026 results with total revenue of $222.8 million, a 1% decrease year-over-year. Military/government service revenue grew 40% year-over-year and 20% sequentially, marking a record quarter. Net loss was $2.0 million with adjuste…

GOGO

Aug 6, 2026

Maya Rios

Press Releases

Tilray Brands Expands THC Beverage Innovation with the Launch of Mollo Lite Blackberry Lemon Seltzer Multi-Pack

Tilray Brands, Inc. announced the launch of the Mollo Lite Blackberry Lemon Seltzers 4-Pack, introducing its first light THC beverage multi-pack in Canada. This low-dose, sessionable cannabis beverage format targets adult consumers seeking approachable potency with refreshing flavor and convenient multi-pack options. The product enhances Tilray's l…

TLRY

Aug 6, 2026

Jordan Park

Press Releases

Lee Enterprises Reports Strong Third Quarter Results and Increases 2026 Fiscal Year Outlook

Lee Enterprises, a digital-first local news and advertising platform, announced strong preliminary Q3 fiscal 2026 results, including $5 million net income and a 23% year-over-year increase in Adjusted EBITDA. Digital revenue now constitutes 57% of total revenue, reflecting successful digital transformation. The company increased its fiscal 2026 Adj…

LEE

Aug 6, 2026

Marcus Reed

Press Releases

GH Research Reports Second Quarter 2026 Financial Results and Provides Business Update

GH Research PLC reported financial results for Q2 2026, highlighting successful completion of Phase 1 trials and FDA alignment on CMC and device plans for their Phase 3 pivotal program targeting treatment-resistant depression (TRD). The company strengthened its US and EU patent portfolio for mebufotenin therapies, published positive Phase 2a postpa…

GHRS

Aug 6, 2026

Nina Shah

Press Releases

Commerce Announces Second Quarter 2026 Financial Results

Commerce.com, Inc. announced its Q2 2026 financial results, posting total revenue of $84.5 million, a slight increase YoY, and a 14% growth in Gross Merchandise Volume. For the second consecutive quarter, the company reported positive GAAP net income of $1.1 million and improved non-GAAP operating income and adjusted EBITDA. Investments continue in…

CMRC

Aug 6, 2026

Jordan Park

Press Releases

Capital City Bank Earns 15th Consecutive “Best Companies” Honor, Ranks in Top 10

Capital City Bank Group, Inc. has been recognized for the 15th consecutive year on Florida Trend's annual "Best Companies to Work For in Florida" list, rising to No. 8 in the large company category in 2026. This accolade highlights the bank's commitment to a supportive and empowering workplace. Additional recognitions include Forbes ranking the ban…

CCBG

Aug 6, 2026

Hana Yamamoto

Press Releases

Resolute Holdings Reports Second Quarter 2026 Results

Resolute Holdings Management, Inc. reported second-quarter fiscal 2026 financial results showing a net loss per share of $1.53 under GAAP, primarily impacted by consolidation of GPGI Holdings. However, non-GAAP fee-related earnings per share increased significantly to $0.69, driven by new and expanded management agreements. The company repurchased …

RHLD

Aug 6, 2026

Hana Yamamoto

Press Releases

Aclaris Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate and Clinical Update

Aclaris Therapeutics released its Q2 2026 financial results, showing increased net loss due to expanded R&D investing in pipeline candidates. The company reaffirmed timelines for pivotal clinical data readouts from multiple Phase 1b and Phase 2 trials targeting immuno-inflammatory diseases such as asthma, atopic dermatitis, and lichen planus. It al…

ACRS

Aug 6, 2026

Ajmal Hussain

Press Releases

More Americans Have Access to Credit While Debt Growth Has Moderated

TransUnion's Q2 2026 Credit Industry Insights Report reveals that consumer credit access in the U.S. continues to expand steadily with total outstanding balances reaching $18.6 trillion. Lenders are managing risk through strategies like smaller credit lines, resulting in stable delinquency rates despite moderate increases in debt usage. Growth in c…

TRU

Aug 6, 2026

Maya Rios

Press Releases

Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology

Pharvaris announced the publication of a landmark qualitative study assessing the burden of acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), highlighting significant patient challenges including frequent misdiagnoses and multifaceted impacts on quality of life. The study validated patient-reported outcome measures which are now infor…

PHVS

Aug 6, 2026

Marcus Reed

Press Releases

Brilliant Earth Reports Second Quarter Results and Raises Annual Profitability Guidance

Brilliant Earth Group, Inc. delivered solid second quarter results in 2026, with 6% year-over-year net sales growth, $5.8 million in adjusted EBITDA exceeding the upper end of guidance, and substantial bookings growth in fine jewelry. The company expanded its gross margin and improved operating expense leverage while opening a new flagship showroom…

BRLT

Aug 6, 2026

Priya Menon

Press Releases

Onity Group Announces Second Quarter 2026 Results

Onity Group Inc. announced its Q2 2026 results showing record origination volumes and significant subservicing additions which drove double-digit revenue and servicing growth. However, the company reported a net loss of $13 million largely due to $9 million in costs from asset sales and servicing transfers, and $24 million in unfavorable asset fair…

ONIT

Aug 6, 2026

Avery Klein

Press Releases

Kinross upgraded to ‘BBB’ Rating by S&P Global Ratings

Kinross Gold Corporation received a credit rating upgrade from S&P Global Ratings, improving its long-term issuer credit and unsecured debt ratings from 'BBB-' to 'BBB' with a stable outlook. The upgrade recognizes Kinross’s strengthened financial position driven by strong cash flow, debt reduction, and operational discipline, underpinned by a net …

KGC

Aug 6, 2026

Avery Klein

Press Releases

Bullish releases July 2026 monthly metrics

Bullish, a US-listed digital asset platform focused on institutional crypto trading and market infrastructure, released its unaudited monthly metrics for July 2026. These include detailed metrics on trading volumes, average trading spreads, and volatility for major cryptocurrencies BTC and ETH, derived from its proprietary CoinDesk data services. T…

BLSH